Cargando…

Short-chain methotrexate polyglutamate MTXPG2 as outcome parameter in rheumatoid arthritis

Detalles Bibliográficos
Autores principales: Hobl, Eva-Luise, Jilma, Bernd, Erlacher, Ludwig, Mader, Robert
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016546/
http://dx.doi.org/10.1186/1471-2210-10-S1-A35
_version_ 1782195769339543552
author Hobl, Eva-Luise
Jilma, Bernd
Erlacher, Ludwig
Mader, Robert
author_facet Hobl, Eva-Luise
Jilma, Bernd
Erlacher, Ludwig
Mader, Robert
author_sort Hobl, Eva-Luise
collection PubMed
description
format Text
id pubmed-3016546
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30165462011-01-07 Short-chain methotrexate polyglutamate MTXPG2 as outcome parameter in rheumatoid arthritis Hobl, Eva-Luise Jilma, Bernd Erlacher, Ludwig Mader, Robert BMC Pharmacol Meeting Abstract BioMed Central 2010-11-16 /pmc/articles/PMC3016546/ http://dx.doi.org/10.1186/1471-2210-10-S1-A35 Text en Copyright ©2010 Hobl et al; licensee BioMed Central Ltd.
spellingShingle Meeting Abstract
Hobl, Eva-Luise
Jilma, Bernd
Erlacher, Ludwig
Mader, Robert
Short-chain methotrexate polyglutamate MTXPG2 as outcome parameter in rheumatoid arthritis
title Short-chain methotrexate polyglutamate MTXPG2 as outcome parameter in rheumatoid arthritis
title_full Short-chain methotrexate polyglutamate MTXPG2 as outcome parameter in rheumatoid arthritis
title_fullStr Short-chain methotrexate polyglutamate MTXPG2 as outcome parameter in rheumatoid arthritis
title_full_unstemmed Short-chain methotrexate polyglutamate MTXPG2 as outcome parameter in rheumatoid arthritis
title_short Short-chain methotrexate polyglutamate MTXPG2 as outcome parameter in rheumatoid arthritis
title_sort short-chain methotrexate polyglutamate mtxpg2 as outcome parameter in rheumatoid arthritis
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016546/
http://dx.doi.org/10.1186/1471-2210-10-S1-A35
work_keys_str_mv AT hoblevaluise shortchainmethotrexatepolyglutamatemtxpg2asoutcomeparameterinrheumatoidarthritis
AT jilmabernd shortchainmethotrexatepolyglutamatemtxpg2asoutcomeparameterinrheumatoidarthritis
AT erlacherludwig shortchainmethotrexatepolyglutamatemtxpg2asoutcomeparameterinrheumatoidarthritis
AT maderrobert shortchainmethotrexatepolyglutamatemtxpg2asoutcomeparameterinrheumatoidarthritis